These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22713596)

  • 21. Cytokines, from atopy to asthma: the Th2 dogma revisited.
    Magnan A; Boniface S; Mély L; Romanet S; Mamessier E; Vervloet D
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):679-87. PubMed ID: 11502075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Academy of Allergy, Asthma & Immunology: Virtual annual meeting, February 26 to March 1, 2021.
    EBioMedicine; 2021 Jun; 68():103394. PubMed ID: 34038859
    [No Abstract]   [Full Text] [Related]  

  • 23. [Directions of investigations for new drugs in asthma].
    Płusa T
    Pol Merkur Lekarski; 2009 Jan; 26(151):5-8. PubMed ID: 19391498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis.
    Cox L; Platts-Mills TA; Finegold I; Schwartz LB; Simons FE; Wallace DV; ;
    J Allergy Clin Immunol; 2007 Dec; 120(6):1373-7. PubMed ID: 17996286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma.
    Kierstein S
    IDrugs; 2006 Jun; 9(6):405-8. PubMed ID: 16752308
    [No Abstract]   [Full Text] [Related]  

  • 26. Allergic inflammation: where epithelial function interacts with immune response in atopic diseases.
    Godoy L
    Drug News Perspect; 2009 May; 22(4):233-6. PubMed ID: 19536368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel 2-(substituted phenyl)benzimidazole derivatives with potent activity against IgE, cytokines, and CD23 for the treatment of allergy and asthma.
    Richards ML; Lio SC; Sinha A; Tieu KK; Sircar JC
    J Med Chem; 2004 Dec; 47(26):6451-4. PubMed ID: 15588078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. American Academy of Allergy, Asthma & Immunology--2008 Annual Meeting.
    Bielory L
    IDrugs; 2008 May; 11(5):309-11. PubMed ID: 18465665
    [No Abstract]   [Full Text] [Related]  

  • 29. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R; Hansel TT
    Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update in allergy and immunology.
    Montanaro A; Tilles SA
    Ann Intern Med; 2001 Feb; 134(4):291-7. PubMed ID: 11182840
    [No Abstract]   [Full Text] [Related]  

  • 31. Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of European Academy of Allergy and Clinical Immunology, American Academy of Allergy and Immunology, European Respiratory Society, American College of Allergy, Asthma and Immunology.
    Moscato G; Godnic-Cvar J; Maestrelli P; Malo JL; Burge PS; Coifman R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):233-8. PubMed ID: 7552924
    [No Abstract]   [Full Text] [Related]  

  • 32. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report.
    Cox L; Lieberman P; Wallace D; Simons FE; Finegold I; Platts-Mills T; Schwartz L
    J Allergy Clin Immunol; 2011 Jul; 128(1):210-2. PubMed ID: 21531014
    [No Abstract]   [Full Text] [Related]  

  • 33. [A brief introduction to 2011 annual meeting of the American Academy of Allergy, Asthma and Immunology].
    Li HB; Liu Z; Xu G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 46(8):702-4. PubMed ID: 22169562
    [No Abstract]   [Full Text] [Related]  

  • 34. Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol; 1999 Dec; 83(6 Pt 3):665-700. PubMed ID: 10616910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in asthma and allergy genetics in 2007.
    Vercelli D
    J Allergy Clin Immunol; 2008 Aug; 122(2):267-71. PubMed ID: 18619666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cell mediators in asthma. Clinical uses of the inhibitors.
    Seropian E; Filip V; Iamandescu I
    Allergol Immunopathol (Madr); 1981; Suppl 9():23-7. PubMed ID: 6187197
    [No Abstract]   [Full Text] [Related]  

  • 37. [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].
    Malling HJ
    Wien Med Wochenschr; 1999; 149(14-15):410-4. PubMed ID: 10584284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulation as asthma therapy: where do we stand?
    Barnes PJ
    Eur Respir J Suppl; 1996 Aug; 22():154s-159s. PubMed ID: 8871062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology.
    Fonacier L; Spergel J; Charlesworth EN; Weldon D; Beltrani V; Bernhisel-Broadbent J; Boguniewicz M; Leung DY; ;
    J Allergy Clin Immunol; 2005 Jun; 115(6):1249-53. PubMed ID: 15940142
    [No Abstract]   [Full Text] [Related]  

  • 40. An insight into molecular mechanisms of human T helper cell differentiation.
    Rautajoki KJ; Kylaniemi MK; Raghav SK; Rao K; Lahesmaa R
    Ann Med; 2008; 40(5):322-35. PubMed ID: 18484344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.